Found: 110
Select item for more details and to access through your institution.
Impact of carotid stenosis on the outcome of stroke patients submitted to reperfusion treatments: a narrative review.
- Published in:
- Reviews in the Neurosciences, 2024, v. 35, n. 5, p. 575, doi. 10.1515/revneuro-2024-0002
- By:
- Publication type:
- Article
The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review.
- Published in:
- Pain & Therapy, 2024, v. 13, n. 3, p. 319, doi. 10.1007/s40122-024-00581-x
- By:
- Publication type:
- Article
Correction: The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 415, doi. 10.1007/s40120-024-00582-0
- By:
- Publication type:
- Article
Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study.
- Published in:
- Toxins, 2024, v. 16, n. 4, p. 178, doi. 10.3390/toxins16040178
- By:
- Publication type:
- Article
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01721-6
- By:
- Publication type:
- Article
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 11, p. 5436, doi. 10.1007/s00415-023-11872-2
- By:
- Publication type:
- Article
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection – A Narrative Review.
- Published in:
- Therapeutics & Clinical Risk Management, 2023, v. 19, p. 959, doi. 10.2147/TCRM.S263824
- By:
- Publication type:
- Article
Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles—A Narrative Review.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 18, p. 13979, doi. 10.3390/ijms241813979
- By:
- Publication type:
- Article
Quantitative and Qualitative Pain Evaluation in Response to OnabotulinumtoxinA for Chronic Migraine: An Observational Real-Life Study.
- Published in:
- Toxins, 2023, v. 15, n. 4, p. 284, doi. 10.3390/toxins15040284
- By:
- Publication type:
- Article
Stroke territory and atherosclerosis in ischemic stroke patients with a history of migraine with aura.
- Published in:
- Frontiers in Neurology, 2023, v. 14, p. 1, doi. 10.3389/fneur.2023.1142424
- By:
- Publication type:
- Article
Effective Intracerebral Connectivity in Acute Stroke: A TMS–EEG Study.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 2, p. 233, doi. 10.3390/brainsci13020233
- By:
- Publication type:
- Article
Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 1, p. 224, doi. 10.1111/ene.15563
- By:
- Publication type:
- Article
Correction to: Task-switching abilities in episodic and chronic migraine.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1143, doi. 10.1111/head.14400
- By:
- Publication type:
- Article
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 17, p. 10975, doi. 10.3390/ijerph191710975
- By:
- Publication type:
- Article
Gepants — a long way to cure: a narrative review.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 9, p. 5697, doi. 10.1007/s10072-022-06184-8
- By:
- Publication type:
- Article
Atogepant for the Prevention of Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Efficacy and Safety.
- Published in:
- Neurology & Therapy, 2022, v. 11, n. 3, p. 1235, doi. 10.1007/s40120-022-00370-8
- By:
- Publication type:
- Article
Cerebral Hemodynamics, Right-to-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 14, p. 8575, doi. 10.3390/ijerph19148575
- By:
- Publication type:
- Article
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Task-switching abilities in episodic and chronic migraine.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 6, p. 3803, doi. 10.1007/s10072-021-05837-4
- By:
- Publication type:
- Article
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study).
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01396-x
- By:
- Publication type:
- Article
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 4, p. 1198, doi. 10.1111/ene.15197
- By:
- Publication type:
- Article
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01408-w
- By:
- Publication type:
- Article
Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 2, p. 897, doi. 10.1007/s00415-021-10671-x
- By:
- Publication type:
- Article
When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?
- Published in:
- Journal of Neurology, 2022, v. 269, n. 2, p. 1032, doi. 10.1007/s00415-021-10772-7
- By:
- Publication type:
- Article
Carotid Artery Plaque Progression: Proposal of a New Predictive Score and Role of Carotid Intima-Media Thickness.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 2, p. 758, doi. 10.3390/ijerph19020758
- By:
- Publication type:
- Article
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01363-y
- By:
- Publication type:
- Article
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.774341
- By:
- Publication type:
- Article
The Genetic Landscape of Patent Foramen Ovale: A Systematic Review.
- Published in:
- Genes, 2021, v. 12, n. 12, p. 1953, doi. 10.3390/genes12121953
- By:
- Publication type:
- Article
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients.
- Published in:
- Pain & Therapy, 2021, v. 10, n. 2, p. 1605, doi. 10.1007/s40122-021-00328-y
- By:
- Publication type:
- Article
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1351, doi. 10.1111/head.14194
- By:
- Publication type:
- Article
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) project.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 6, p. 936, doi. 10.1111/head.14123
- By:
- Publication type:
- Article
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study.
- Published in:
- Pain & Therapy, 2021, v. 10, n. 1, p. 637, doi. 10.1007/s40122-021-00253-0
- By:
- Publication type:
- Article
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01247-1
- By:
- Publication type:
- Article
Pathophysiological Bases of Comorbidity in Migraine.
- Published in:
- Frontiers in Human Neuroscience, 2021, p. N.PAG, doi. 10.3389/fnhum.2021.640574
- By:
- Publication type:
- Article
Commentary: Enhanced Hemodynamic and Clinical Response to αCGRP in Migraine Patients—A TCD Study.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.663818
- By:
- Publication type:
- Article
Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 2, p. 363, doi. 10.1111/head.14032
- By:
- Publication type:
- Article
Erenumab does not alter cerebral hemodynamics and endothelial function in migraine without aura.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 90, doi. 10.1177/0333102420956692
- By:
- Publication type:
- Article
Migraineurs' psychological traits do not influence response to erenumab.
- Published in:
- Neurological Sciences, 2020, v. 41, p. 467, doi. 10.1007/s10072-020-04661-6
- By:
- Publication type:
- Article
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study).
- Published in:
- Neurological Sciences, 2020, v. 41, p. 487, doi. 10.1007/s10072-020-04669-y
- By:
- Publication type:
- Article
Poor sleep quality in patients affected by migraine: a population study.
- Published in:
- Neurological Sciences, 2020, v. 41, p. 495, doi. 10.1007/s10072-020-04673-2
- By:
- Publication type:
- Article
Drug withdrawal along with bridge therapy with methylprednisolone and/or diazepam for treatment of medication overuse headache: a preliminary report from the WASH-OUT study.
- Published in:
- Neurological Sciences, 2020, v. 41, p. 499, doi. 10.1007/s10072-020-04675-0
- By:
- Publication type:
- Article
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study.
- Published in:
- Neurological Sciences, 2020, v. 41, n. 12, p. 3385, doi. 10.1007/s10072-020-04767-x
- By:
- Publication type:
- Article
Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache.
- Published in:
- Frontiers in Human Neuroscience, 2020, v. 14, p. N.PAG, doi. 10.3389/fnhum.2020.571035
- By:
- Publication type:
- Article
The Healthy Eating Plate Advice for Migraine Prevention: An Interventional Study.
- Published in:
- Nutrients, 2020, v. 12, n. 6, p. 1579, doi. 10.3390/nu12061579
- By:
- Publication type:
- Article
Onabotulinumtoxin‐A in Chronic Migraine: Should Timing and Definition of Non‐Responder Status Be Revised? Suggestions From a Real‐Life Italian Multicenter Experience.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 8, p. 1300, doi. 10.1111/head.13617
- By:
- Publication type:
- Article
Influence of chronotype on migraine characteristics.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Right-to-left shunts and hormonal therapy influence cerebral vasomotor reactivity in patients with migraine with aura.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220637
- By:
- Publication type:
- Article